Regenerative

Exosome Therapy

Cell-free regenerative signaling that amplifies the power of our stem cell protocols.

Exosome therapy uses extracellular vesicles derived from mesenchymal stem cells to deliver targeted regenerative signals to damaged tissues. At ARDIG, exosome therapy is never used as a standalone treatment - it is always administered as a complement to our stem cell protocols, enhancing the regenerative environment and improving signaling between cells. This combined approach is available at all ARDIG locations.

Book a Consultation Am I a Candidate?

How ARDIG Uses Exosome Therapy

Exosomes work synergistically with our stem cell protocols, boosting the regenerative response in every treatment.

What Are Exosomes?

Exosomes are nano-sized vesicles (30-150 nm) naturally secreted by mesenchymal stem cells. They carry proteins, lipids, mRNA, and microRNA that instruct target cells to reduce inflammation, promote tissue repair, and modulate immune responses. Unlike whole cells, exosomes are cell-free, making them a powerful signaling tool with a favorable safety profile.

Combined Protocol

At ARDIG, exosome therapy is always paired with one of our stem cell protocols. The exosomes are administered alongside or shortly after the stem cell infusion, creating an optimal regenerative microenvironment. This combined approach allows the transplanted stem cells to receive enhanced repair signals, improving engraftment and therapeutic outcomes.

Delivery & Dosing

Exosomes are administered intravenously (IV) or intra-arterially (IA) as part of the same treatment session as the stem cell infusion, depending on the condition and protocol. Dosing is calibrated according to the patient's condition, body weight, and the specific stem cell protocol being applied. This therapy is available at all ARDIG locations worldwide.

Am I a Candidate?

Exosome therapy is offered as an enhancement to our stem cell protocols. Candidacy is determined together with your overall treatment plan.

  • Already approved as a candidate for one of ARDIG's stem cell therapy protocols
  • Condition involves significant tissue damage or chronic inflammation that may benefit from enhanced cell signaling
  • Physician determines that adding exosomes to the protocol could amplify the therapeutic response
  • No contraindications to the underlying stem cell protocol (exosomes are not administered alone)

Important Note

Exosome therapy is not a standalone service at ARDIG. It is always administered as part of a stem cell protocol designed by our physicians. If you are a candidate for stem cell therapy, your doctor will discuss whether adding exosomes may benefit your specific case.

Get Evaluated

What to Expect

From your first consultation to ongoing follow-up, here is what the ARDIG journey looks like.

1

Free Consultation

Schedule a no-obligation call with one of our physicians to discuss your condition and treatment options.

2

Medical Evaluation

Our medical team reviews your records and determines if you are a candidate for our programs.

3

Schedule & Treatment

After medical evaluation and approval, choose your preferred treatment date and travel to one of our facilities for your scheduled treatment program.

4

Ongoing Care

After returning home, your ARDIG physician monitors your progress through scheduled telehealth appointments.

Risks & Limitations

Transparency is a core ARDIG value. We believe every patient deserves to understand both the potential benefits and the limitations of any treatment.

General Risks

Exosome therapy is considered to have a favorable safety profile since it is cell-free. Potential risks are similar to those of intravenous infusions and include mild fever, headache, or temporary fatigue. Because exosomes are always administered alongside stem cell therapy at ARDIG, the risk profile of the combined treatment should also be considered.

Current Limitations

Exosome research is a rapidly evolving field. While early clinical evidence and preclinical studies show promising regenerative signaling effects, large-scale randomized controlled trials are ongoing. Exosomes are not a cure and are used at ARDIG exclusively to enhance stem cell protocols, not as a replacement for them.

Results vary by patient. Regenerative medicine is an evolving field and outcomes cannot be guaranteed. Consult with our physicians for a realistic assessment.

Related Conditions

This therapy is used within ARDIG's treatment programs for the following conditions.

Autism Spectrum Disorder
Duchenne Muscular Dystrophy
Heart Failure
Multiple Sclerosis
Autoimmune Conditions

FAQ

Exosomes are tiny vesicles (30-150 nanometers) released naturally by stem cells. They carry biological signals - including proteins, lipids, and genetic material - that communicate with other cells, telling them to reduce inflammation, repair damage, and modulate immune responses. They are sometimes called the "messengers" of regenerative medicine.

No. At ARDIG, exosome therapy is always administered as part of a stem cell protocol. We believe the combined approach yields the best results because the exosomes help prepare the tissue environment for the stem cells and enhance cell-to-cell communication. We do not offer exosome therapy as a standalone treatment.

Exosome-enhanced stem cell protocols are available at all ARDIG locations, including Mexico, Peru, and the United States. Exosomes are administered via IV or intra-arterial routes as part of the stem cell treatment session, so no additional travel or separate procedures are required.

Stem cells are living cells capable of self-renewal and tissue repair. Exosomes are non-living vesicles that carry the regenerative signals stem cells produce. While stem cells do the rebuilding, exosomes amplify the instructions, creating a more effective healing environment. Together, they make a powerful combination.

Exosomes are cell-free and generally well-tolerated. The risk profile is similar to the underlying stem cell procedure. Some patients may experience mild and temporary side effects such as low-grade fever or fatigue. Your physician will discuss the complete risk profile of your combined treatment plan.

There may be an additional cost associated with exosome therapy depending on the dosing and protocol. During your consultation, your physician and patient coordinator will provide a complete breakdown of costs. ARDIG is committed to transparency in pricing.

Reach us

We reply within 24 hours Your information is private and secure